Diabetes mellitus (DM) is a major medical and public health concern worldwide. In 2014, it has been estimated that there were 382 million sufferers of diabetes worldwide.[@ref1] The prevalence of diabetes in Saudi Arabia is 23.9%, which is among the highest in the gulf area and the world.[@ref1],[@ref2] Type-2 diabetes mellitus (T2DM) represents approximately 90-95% of all diabetes cases.[@ref3] Type-2 diabetes mellitus is characterized by high blood glucose due to the inability of body cells to respond to insulin, a phenomenon known as insulin resistance.[@ref4] The genetic factors behind the insulin resistance are not well-understood and are under intensive research. Insulin is a metabolically important peptide hormone secreted from ß-cells of the pancreas in response to high blood glucose. Insulin signaling starts with binding of the insulin molecule to its cognate membrane insulin receptor (IR). This binding triggers conformational changes in the juxtamembrane intracellular region of the receptor causing autophosphorylation of certain tyrosine residues. The activated receptor then phosphorylates and activates a family of intracellular effector proteins known as insulin receptor substrates 1 to 4 (IRS-1 to 4).[@ref5] These activated proteins then interact with the regulatory subunit (p85) of the enzyme phosphatidylinositol (PI) 3-kinase causing glucose transporter-4 (Glut-4) translocation to the cell membrane to increase glucose uptake.[@ref6] In this signaling pathway, *IRS1* seems to play a major role as suggested by *IRS1* knockout mice studies.[@ref7] Additionally, several polymorphisms in the *IRS1* gene were associated with insulin resistance, obesity, and T2DM.[@ref8],[@ref9] The single nucleotide polymorphism (SNP) (rs1801278) in the *IRS1* gene causing an amino acid substitution where glycine (GGG) is replaced by arginine (AGG) at codon 972 was first described by Almind et al.[@ref10] It is the most widely studied candidate of the *IRS1* gene variants by testing its association with insulin resistance and T2DM.[@ref11] However, the association of this polymorphism with the development of T2DM has not been consistent around the world. In a study focusing on Mexican participants, Burguete-Garcia et al[@ref8] found that the *IRS1* Gly972Arg variant was significantly associated with T2DM. Another study that also focused on Mexican population similarly found a significant association between Gly972Arg variant and genetic susceptibility to T2DM.[@ref12] A study on Indian population from Hyderabad also reported significant association with T2DM.[@ref13] A meta-analysis study conducted in 2009 of 30 studies had shown that there was no significant association between the *IRS1* Gly972Arg variant and T2DM.[@ref11] In addition, previous studies also reported no association between the *IRS1* Gly972Arg polymorphism and T2DM.[@ref14]-[@ref18] There is no report on the frequency of this polymorphism and its association with T2DM in the Eastern Province of Saudi Arabia. Thus, the aim of the current work is to examine the association between the *IRS1* Gly972Arg polymorphism with T2DM among Saudis.

Methods {#sec1-2}
=======

The literature review search methods included using PubMed, Google Scholar, and Summon Web Scale Discovery databases to search for the following words: *IRS1*, diabetes AND IRS, insulin receptor substrate 1, *IRS1* polymorphism, Gly972Arg, and G972R. Using these words, we generated a recent study on polymorphism. In addition, all studies mentioned in the meta-analysis article were collected and critically read.[@ref11]

An informed consent was collected from all subjects involved in this study (IRB-2014-04-284) for institutional local ethics approval granted by the University of Dammam, Saudi Arabia. The study was conducted in accordance with the Declaration of Helsinki. The study design is a case-control study. Volunteer subjects were recruited from the outpatient clinic at King Fahad Hospital of the University (KFHU), University of Dammam, Al-Khobar, and Eastern Province, Saudi Arabia between May and December 2014. A total of 143 subjects from both genders, with an average age of 47.2 years (range 35-73 years), participated in this study. They were divided as 74 healthy non-diabetic control group and 69 subjects with T2DM. Demographic data such as age, gender, height, weight, body mass index (BMI) and family history of diabetes were determined from all subjects.

Two blood samples were drawn from each subject after an overnight fast in 7 ml of ethylenediaminetetraacetic acid (EDTA) and plain tubes. The serum from plain tubes was recovered and sent for routine clinical chemistry laboratory for blood glucose measurement. The EDTA whole blood was used for subsequent DNA extraction analysis. The genomic DNA was extracted from 200 µl of the whole blood leukocytes using DNA extraction kit (GE Healthcare Life Sciences Ltd, Buckinghamshire, UK). The extracted DNA concentration ranged from 10-25 ng/µl. The DNA purity was checked by OD260:OD280 ratio of 1.8 ± 1. All DNA samples were then stored at -20 ºC until the genetic analysis was performed. The *IRS1* Gly972Arg polymorphism in all subjects was genotyped using the standard polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. First, the DNA area in *IRS1* gene flanking the polymorphism was amplified by PCR. The PCR reaction was carried out at a final volume of 25 µl as: 1µl of sample DNA, 1 µl of each primer (forward; 5' GCT TTC CAC AGC TCA CCT TC 3', reverse; 5' TTT AAA TTT AAA TTT AAA TTT AAA TTT AAA TTT GGT AGG CCT GCA AAT GCT A 3'), and 9.5 µl of sterile nucleic acid free H~2~O. The above mixture was then mixed with 12.5 µl of 2x PCR master mix (Promega; Wisconsin, USA). The reverse primer was designed to contain additional 33 unbound (TTTAAA) nucleotide repeats to increase the PCR product size to 321 base pair (bp) and further enhance difference in sizes between digested DNA fragments later. The initial PCR thermal profile was denaturation (94°C, 4 minutes) followed by 35 repeated cycles of denaturation (94°C, 30 seconds), annealing (58°C, 30 seconds), elongation (72°C, 30 seconds), and final extension (72°C, 10 minutes). The amplified PCR product (231 bp) was digested with the XmaI restriction endonuclease according to following reaction mixture: 5 µl of the PCR product, 2 µl of bovine serum albumin, 2 µl of 10x digestion buffer, 10 µl of sterile nucleic acid free H~2~O, and 1 µl of the restriction enzyme. The digestion mixture was incubated for 2 hours at 37°C and run on 2.5% agarose gel stained with ethidium bromide. As the *IRS1* Gly972Arg allele polymorphism disrupts a recognition site for the XmaI enzyme, the presence of 2 DNA fragments at 169 and 62 bp indicated normal non-mutated alleles. Heterozygous genotypes were indicated by the presence of 3 bands at 231, 169, 62 bp while the homozygous mutated genotype was indicated by the presence of one band at 231 bp.

Data from both control and diabetic groups were presented as mean±standard deviation (SD) or percentages for non-continuous variables. The statistical significance was measured by simple student t-test, or Fisher's exact test if both variables were dichotomous. Relationship between the *IRS1* Gly972Arg polymorphism and T2DM was evaluated using the logistic regression testing by calculating odds ratios in addition to 95% confidence intervals (CI) and a p-value based on Fisher's exact test to indicate the statistical significance. To avoid differences that may result from confounding factors such as age, gender, or BMI, data were stratified into categories by gender (male/female), age (\>40/\<40 years old), or BMI (\>30 kg/m^2^ and \<30 kg/m^2^), and re-analyzed separately. The odds ratios, 95% CI, and p-values were then pooled to one common adjusted value using Mantel-Haenszel method. Statistical analyses were carried out using GraphPad prism 6 software (GraphPad Software Inc., La Jolla, CA, USA). A p-value of \<0.05 was considered statistically significant.

Results {#sec1-3}
=======

The baseline characteristics of the study population are summarized in [**Table 1**](#T1){ref-type="table"}. To evaluate the familial effect on the *IRS1* genotypes in 143 total population of the study, the observed genotype frequencies were compared to the expected frequencies. Data showed similar values with a Chi-squared *p*=0.31 indicating that all genotypes reached the Hardy-Weinberg equilibrium ([**Table 2**](#T2){ref-type="table"}).
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Baseline characteristic of the control and type-2 diabetes mellitus (T2DM) subjects.
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Consistency with Hardy-Weinberg equilibrium.
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The overall frequency of the *IRS1* Gly972Arg variant in the total study population was 9.8% with only one subject carrying the homozygous mutant genotype (Arg/Arg) ([**Table 3**](#T3){ref-type="table"}). Considering control and diabetic groups separately, frequencies were 8.7% and 10.8%. Allelic frequencies in total population were 94.8% for Gly allele and 5.2% for Arg allele. To evaluate the association between the presence of the Arg allele and T2DM, logistic regression analysis was conducted using the Gly/Gly genotype as a non-exposed reference ([**Table 3**](#T3){ref-type="table"}). Adjusted odds ratios were 1.06 (95% CI: 0.3 - 4.0) for the Gly/Arg variant carriers and 1.04 (95% CI: 0.28 - 3.95) for subjects that carry either Gly/Arg or Arg/Arg variants. Therefore, there was no statistically significant association between the presence of the Arg allele and the occurrence of T2DM. Analysis based on allelic frequencies showed an odds ratio of 0.83 (95% CI: 0.2 - 2.8) for the Arg allele to develop T2DM.

###### 

Genotype and allele distribution of the insulin receptor substrate-1 Gly972Arg polymorphism in type-2 diabetic patients and healthy control group.
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Discussion {#sec1-4}
==========

Insulin receptor substrate-1 is an essential component in the insulin signaling pathway. The common polymorphism in the *IRS1* gene Gly972Arg has been shown to affect the appropriate function of the *IRS1* protein.[@ref19] Structurally, this polymorphism is positioned between 2 potential sites of tyrosine phosphorylation (Tyr941 and Tyr989) in *IRS1* that are necessary for binding to the p85 subunit of the effector molecule PI3K during insulin signaling.[@ref20],[@ref21] Accordingly, this mutation has been shown to alter the *IRS1* interaction with tyrosine protein kinases, decrease the PI3K activation and contribute to insulin resistance.[@ref9],[@ref19],[@ref22],[@ref23] In this case-control study, we intended to determine any relationship between the *IRS1* Gly972Arg polymorphism and T2DM among Saudi Arabian population in the Eastern Province. The results showed that 10.8% of the control group carried at least one copy of the mutated Arg allele variant, while most of the subjects were normal. Similar distribution was also found in the diabetic group and the logistic regression analysis revealed no association between the *IRS1* Gly972Arg polymorphism and T2DM. Our finding might contradict with some published reports that suggested an association, including a recently published study based in the middle area of the country.[@ref24] However, the association between the *IRS1* Gly972Arg variant with T2DM has been controversial throughout the literature and the lack of association has been also reported in multiple studies.[@ref14]-[@ref18] For example, in a published meta-analysis study reviewing more than 30 studies and involving 12,076 diabetic cases and 11,285 controls found no statistically significant association between this polymorphism and T2DM.[@ref11] Therefore, the *IRS1* Gly972Arg polymorphism might not be a major element of the genetic architecture necessary for development of T2DM. However, if present, this polymorphism might contribute to a more complicated and difficult to control form of T2DM. It has been linked to impaired glucose tolerance,[@ref25] poor glycemic control,[@ref9] decreased glomerular filtration rate,[@ref26] increased levels of triglyceride,[@ref26] failure of oral treatment[@ref27] impaired insulin secretion from the ß-cell of the pancreas,[@ref20] and beta cells apoptosis.[@ref28] The limitations of this study include the small sample size and lack of a variable that could measure insulin resistance.

In conclusion, our findings did not support the association between the *IRS1* Gly972Arg polymorphism and T2DM among Saudis from the Eastern Province. Therefore, the presence or absence of this polymorphism may not be a main determinant for the development of T2DM. However, further research with larger sample size may be required to establish an accurate relationship.
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